Annual Colloquium on Cell & Gene Therapy and Advanced Biotherapeutics
Convening academic principal investigators, clinical trialists, and molecular vector engineers to evaluate high-fidelity gene editing, synthetic cellular immunology, and non-viral nucleic acid delivery pipelines.
Bridging Preclinical Precision with Clinical Scalability
While viral and cellular engineering breakthroughs continue to transform rare disease and oncology landscapes, major clinical bottlenecks persist across vector manufacturing, off-target detection, in vivo immunogenicity, and solid tumor microenvironment suppression.
CellGene 2027 operates as a rigorous translational forum designed to accelerate laboratory findings into audited Phase I/II trial designs, matching academic faculty with bioprocessing engineers and clinical investigators.
Participating Delegate Profiles
The colloquium brings together specialized stakeholders across the advanced biotherapeutics ecosystem:
- Academic Lab Heads & PIs: Directing functional genomics, synthetic biology, and vector development laboratories.
- Clinical Trialists & Oncologists: Leading autologous and allogeneic cellular trials across university medical centers.
- Bioengineers & Process Developers: Optimizing closed-system automated cell processing, LNP encapsulation, and viral titer yields.
- Regulatory & CMC Directors: Auditing vector purity, cGMP release testing, and IND-enabling safety packages.
Four Core Tracks in Advanced Therapeutics
Peer-reviewed abstract evaluations are organized across dedicated scientific domains to connect clinical faculty with molecular engineering breakthroughs.
CAR-T, CAR-NK & Engineered Cellular Immunotherapy
Next-generation cell architectures combating antigen escape, allogeneic off-the-shelf platforms, and solid tumor microenvironment infiltration.
- Dual-targeting & tandem CAR architectures
- Allogeneic iPSC-derived CAR-NK cells
- T-cell exhaustion reversal & metabolic conditioning
CRISPR, Base Editing & In Vivo Genomic Engineering
High-fidelity precision nucleases, prime editing optimizations, and rigorous protocols for measuring and mitigating off-target mutagenesis.
- Epigenetic editing without double-strand DNA breaks
- High-throughput GUIDE-seq & off-target screening
- In vivo targeted tissue editing pipelines
Viral (AAV/Lentivirus) & Non-Viral (LNP) Delivery Systems
Engineering enhanced tropism, reducing immunogenicity, and optimizing scalable manufacturing for viral and non-viral delivery modalities.
- Novel synthetic AAV capsid directed evolution
- Lipid nanoparticle (LNP) extrahepatic targeting
- Electroporation & biomembrane mechanical delivery
Regenerative Medicine & Stem Cell Therapeutics
Pluripotent stem cell-derived organ models, in vivo tissue regeneration, GMP compliance, and translational safety in human clinical trials.
- GMP-compliant autologous & allogeneic bioprocessing
- Exosome and extracellular vesicle therapeutic cargo
- Clinical biodistribution & long-term tumorigenicity audits
Presentation Formats & Proceedings Indexing
All accepted proffered abstracts are indexed in the serialized colloquium compendium with permanent citable DOIs.
Plenary Oral Presentation
15-minute podium presentation delivered in the primary colloquium amphitheater, followed by a 5-minute moderated discussion with panel discussants.
Moderated Poster Defense
Dedicated physical poster board allocation across Day 1 and Day 2 exhibition intervals with designated evaluation defense windows for scientific appraisal.
Synchronous Virtual Defense
Live interactive digital presentation stream accommodating overseas faculty unable to travel to the United States due to institutional or visa restrictions.
Submission & Registration Milestones
Abstracts are accepted on a rolling basis with committee decisions returned within 14 business days.
Tiered Delegate Registration Rates
Early-bird rates valid through January 31, 2027. Proforma wire invoices available for university procurement.
- Full 2-Day Plenary & Poster Access
- 14.5 Educational Contact Hours Certificate
- Catered Luncheons & Evening Receptions
- Compendium Proceedings Access
- Podium Defense or Poster Slot Allocation
- 14.5 Accredited Contact Hours Verification
- Official Visa Invitation Support Letter
- Catered Executive Networking Sessions
- Serialized Compendium DOI Indexing
- Complete 2-Day Conference & Floor Access
- Commercial Partnering Suite Access
- Full Delegate Directory with Direct Contact
- Company Listing in Printed Compendium